Convalescent Plasma for Outpatients with Covid-19. Reply.
作者信息
Korley Frederick K, Durkalski-Mauldin Valerie, Callaway Clifton W
机构信息
University of Michigan, Ann Arbor, MI.
Medical University of South Carolina, Charleston, SC.
出版信息
N Engl J Med. 2021 Dec 2;385(23):2206-2207. doi: 10.1056/NEJMc2114591. Epub 2021 Oct 13.
Abstract
摘要
相似文献
1
Convalescent Plasma for Outpatients with Covid-19. Reply.用于新冠门诊患者的康复期血浆。回复。
N Engl J Med. 2021 Dec 2;385(23):2206-2207. doi: 10.1056/NEJMc2114591. Epub 2021 Oct 13.
2
Convalescent Plasma for Outpatients with Covid-19.新冠康复者血浆用于新冠门诊患者治疗
N Engl J Med. 2021 Dec 2;385(23):2205-2206. doi: 10.1056/NEJMc2114591. Epub 2021 Oct 13.
3
Convalescent Plasma for Outpatients with Covid-19.新冠康复者血浆用于新冠肺炎门诊患者
N Engl J Med. 2021 Dec 2;385(23):2206. doi: 10.1056/NEJMc2114591. Epub 2021 Oct 13.
4
Convalescent plasma in outpatients with COVID-19.新冠门诊患者的恢复期血浆治疗
Lancet Respir Med. 2022 Mar;10(3):226-228. doi: 10.1016/S2213-2600(22)00050-9. Epub 2022 Feb 9.
5
Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19.免疫抑制患者 COVID-19 的门诊治疗与疫苗加强恢复期血浆治疗。
mBio. 2024 May 8;15(5):e0040024. doi: 10.1128/mbio.00400-24. Epub 2024 Apr 11.
6
High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial.高滴度亚甲蓝处理的恢复期血浆作为 COVID-19 门诊患者的早期治疗：一项随机、安慰剂对照试验。
Lancet Respir Med. 2022 Mar;10(3):278-288. doi: 10.1016/S2213-2600(21)00545-2. Epub 2022 Feb 9.
7
'Treatment of COVID-19 with convalescent plasma' - Author's reply.《用康复期血浆治疗新型冠状病毒肺炎》——作者回复
Clin Microbiol Infect. 2021 Apr;27(4):639-640. doi: 10.1016/j.cmi.2020.09.039. Epub 2020 Sep 29.
8
Convalescent Plasma for Covid-19. Reply.用于治疗新冠肺炎的康复期血浆。回复。
N Engl J Med. 2022 Sep 8;387(10):955-956. doi: 10.1056/NEJMc2208338.
9
In Reply-How Safe Is COVID-19 Convalescent Plasma?回复——新冠康复者血浆有多安全？
Mayo Clin Proc. 2021 Aug;96(8):2281-2282. doi: 10.1016/j.mayocp.2021.06.010. Epub 2021 Jun 25.
10
Convalescent Plasma for Covid-19 - Making Sense of the Inconsistencies.用于治疗新冠病毒肺炎的康复期血浆——解读其中的不一致之处
N Engl J Med. 2022 May 5;386(18):1753-1754. doi: 10.1056/NEJMe2204332.
引用本文的文献
1
Use of convalescent plasma in the treatment of COVID-19.康复期血浆在新型冠状病毒肺炎治疗中的应用。
Nat Rev Nephrol. 2023 Apr;19(4):271. doi: 10.1038/s41581-023-00690-4.
本文引用的文献
1
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.REGN-COV2，一种中和抗体鸡尾酒疗法，用于治疗门诊新冠患者。
N Engl J Med. 2021 Jan 21;384(3):238-251. doi: 10.1056/NEJMoa2035002. Epub 2020 Dec 17.
2
Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients.新型冠状病毒肺炎患者中 SARS-CoV-2 感染的分子和血清学特征。
Virology. 2020 Dec;551:26-35. doi: 10.1016/j.virol.2020.09.008. Epub 2020 Sep 28.
3
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
Zotero 插件